Mehalick David 4
4 · Coeptis Therapeutics Inc. · Filed Nov 18, 2021
Insider Transaction Report
Form 4
Mehalick David
DirectorCEO and President10% Owner
Transactions
- Sale
Common Stock
2021-11-16−1,200,000→ 1,800,000 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by the reporting person in connection with a divorce settlement.